Bio-Techne Corp at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone. My name is Tejas Savant, and I work on the life sciences team here at JPMorgan. It's my pleasure this afternoon to introduce Charles Kummeth, CEO of Bio-Techne. At the end of his presentation, there will be a breakout with management in the room next door, which is the Elizabethan C, I believe.
With that, I'd like to hand it over to Charles.
Thank you. Well, one thing I know is doing these at the very last day after 12 101s, you get a little hoarse. So sorry about that, but I'll try to speak out loud and that you can actually hear me. It's been a great -- it's been a busy 3 days as all you, I'm sure, are the same. I know you're all with me. I'm just glad it isn't raining this year, right?
So anyway, here's our first slide. We actually have a tagline now, where science intersects innovation. I think everyone likes to be an innovation company, but people -- some people
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
